{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:b045d59d-c5b2-407e-b081-16c9ba3d2948","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T13:07:47.420348+00:00","published_at":"2026-10-17T04:47:07.293807+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:1fceamhwykyu9","event_type":"CFO_CHANGED","effective_at":"2026-03-30","detected_at":"2026-10-17T04:47:07.293807+00:00","subject_ids":["alpha:person:mark-j-daniel","alpha:company:b045d59d-c5b2-407e-b081-16c9ba3d2948"],"caused_claim_ids":["alpha:claim:company:b045d59d-c5b2-407e-b081-16c9ba3d2948:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:0904535d0293a2c58d7bd660355114369473a3866328d03f429b1b3d1ca99f8c"],"summary":"Mark J. Daniel executive of ATOSSA THERAPEUTICS, INC., effective 2026-03-30.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:b5npdj9lmnef","event_type":"CEO_CHANGED","effective_at":"2026-03-30","detected_at":"2026-10-17T04:47:07.293807+00:00","subject_ids":["alpha:person:steven-c-quay-m-d-ph-d","alpha:company:b045d59d-c5b2-407e-b081-16c9ba3d2948"],"caused_claim_ids":["alpha:claim:company:b045d59d-c5b2-407e-b081-16c9ba3d2948:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:c3603463e57c815a7bfe458ed686f751e325d1d1f0255ef7a353f0d7db31fe39"],"summary":"Steven C. Quay, M.D., Ph.D. executive of ATOSSA THERAPEUTICS, INC., effective 2026-03-30.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1lm3ssuo25au8","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-17T04:47:07.293807+00:00","subject_ids":["alpha:person:tessa-cigler-m-d-m-p-h","alpha:company:b045d59d-c5b2-407e-b081-16c9ba3d2948"],"caused_claim_ids":["alpha:claim:company:b045d59d-c5b2-407e-b081-16c9ba3d2948:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:06dbf8fd646217b99b9a1f4f08c0ee9f260734a5d680cc730c457a034794aa8b"],"summary":"Tessa Cigler, M.D., M.P.H. seat on ATOSSA THERAPEUTICS, INC., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:2i2idp1xghx51","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-17T04:47:07.293807+00:00","subject_ids":["alpha:person:jonathan-f-finn-c-f-a","alpha:company:b045d59d-c5b2-407e-b081-16c9ba3d2948"],"caused_claim_ids":["alpha:claim:company:b045d59d-c5b2-407e-b081-16c9ba3d2948:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:06dbf8fd646217b99b9a1f4f08c0ee9f260734a5d680cc730c457a034794aa8b"],"summary":"Jonathan F. Finn, C.F.A. seat on ATOSSA THERAPEUTICS, INC., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:fu2ejahx0jl0","event_type":"DIRECTOR_APPOINTED","effective_at":"2014-01-01","detected_at":"2026-10-17T04:47:07.293807+00:00","subject_ids":["alpha:person:richard-i-steinhart","alpha:company:b045d59d-c5b2-407e-b081-16c9ba3d2948"],"caused_claim_ids":["alpha:claim:company:b045d59d-c5b2-407e-b081-16c9ba3d2948:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:06dbf8fd646217b99b9a1f4f08c0ee9f260734a5d680cc730c457a034794aa8b"],"summary":"Richard I. Steinhart seat on ATOSSA THERAPEUTICS, INC., effective 2014-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:zv08t6cpb2us","event_type":"COMMITTEE_CREATED","effective_at":"2014-01-01","detected_at":"2026-10-17T04:47:07.293807+00:00","subject_ids":["alpha:committee:atossa-therapeutics-inc:audit-chair","alpha:company:b045d59d-c5b2-407e-b081-16c9ba3d2948"],"caused_claim_ids":["alpha:claim:company:b045d59d-c5b2-407e-b081-16c9ba3d2948:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:06dbf8fd646217b99b9a1f4f08c0ee9f260734a5d680cc730c457a034794aa8b"],"summary":"Audit · Chair committee of ATOSSA THERAPEUTICS, INC., effective 2014-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:12q7m0h1va24ev","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2014-01-01","detected_at":"2026-10-17T04:47:07.293807+00:00","subject_ids":["alpha:person:richard-i-steinhart","alpha:committee:atossa-therapeutics-inc:audit-chair"],"caused_claim_ids":["alpha:claim:company:b045d59d-c5b2-407e-b081-16c9ba3d2948:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:06dbf8fd646217b99b9a1f4f08c0ee9f260734a5d680cc730c457a034794aa8b"],"summary":"Richard I. Steinhart member of Audit · Chair, effective 2014-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1as8gq4l1rxdg","event_type":"DIRECTOR_APPOINTED","effective_at":"2012-01-01","detected_at":"2026-10-17T04:47:07.293807+00:00","subject_ids":["alpha:person:h-lawrence-remmel-esq","alpha:company:b045d59d-c5b2-407e-b081-16c9ba3d2948"],"caused_claim_ids":["alpha:claim:company:b045d59d-c5b2-407e-b081-16c9ba3d2948:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:06dbf8fd646217b99b9a1f4f08c0ee9f260734a5d680cc730c457a034794aa8b"],"summary":"H. Lawrence Remmel, Esq. seat on ATOSSA THERAPEUTICS, INC., effective 2012-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1gvg21ex66nek","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2012-01-01","detected_at":"2026-10-17T04:47:07.293807+00:00","subject_ids":["alpha:person:h-lawrence-remmel-esq","alpha:committee:atossa-therapeutics-inc:audit"],"caused_claim_ids":["alpha:claim:company:b045d59d-c5b2-407e-b081-16c9ba3d2948:committee_record:14"],"evidence_ids":["alpha:projection-evidence:f6ec3d301d4c0f19bc71c247598f1515e024c704a82ffbc57bb048789c211f40"],"summary":"H. Lawrence Remmel, Esq. member of Audit, effective 2012-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:mz02sl9n2ujj","event_type":"DIRECTOR_APPOINTED","effective_at":"2011-01-01","detected_at":"2026-10-17T04:47:07.293807+00:00","subject_ids":["alpha:person:stephen-j-galli-m-d","alpha:company:b045d59d-c5b2-407e-b081-16c9ba3d2948"],"caused_claim_ids":["alpha:claim:company:b045d59d-c5b2-407e-b081-16c9ba3d2948:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:06dbf8fd646217b99b9a1f4f08c0ee9f260734a5d680cc730c457a034794aa8b"],"summary":"Stephen J. Galli, M.D. seat on ATOSSA THERAPEUTICS, INC., effective 2011-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:zd4nanik7ruj","event_type":"DIRECTOR_APPOINTED","effective_at":"2009-01-01","detected_at":"2026-10-17T04:47:07.293807+00:00","subject_ids":["alpha:person:shu-chih-chen-ph-d","alpha:company:b045d59d-c5b2-407e-b081-16c9ba3d2948"],"caused_claim_ids":["alpha:claim:company:b045d59d-c5b2-407e-b081-16c9ba3d2948:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:06dbf8fd646217b99b9a1f4f08c0ee9f260734a5d680cc730c457a034794aa8b"],"summary":"Shu-Chih Chen, Ph.D. seat on ATOSSA THERAPEUTICS, INC., effective 2009-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:2zmzma9pzhdm","event_type":"DIRECTOR_APPOINTED","effective_at":"2009-01-01","detected_at":"2026-10-17T04:47:07.293807+00:00","subject_ids":["alpha:person:steven-c-quay-m-d-ph-d","alpha:company:b045d59d-c5b2-407e-b081-16c9ba3d2948"],"caused_claim_ids":["alpha:claim:company:b045d59d-c5b2-407e-b081-16c9ba3d2948:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:06dbf8fd646217b99b9a1f4f08c0ee9f260734a5d680cc730c457a034794aa8b"],"summary":"Steven C. Quay, M.D., Ph.D. seat on ATOSSA THERAPEUTICS, INC., effective 2009-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:b045d59d-c5b2-407e-b081-16c9ba3d2948:leadership_role:5","subject_id":"alpha:company:b045d59d-c5b2-407e-b081-16c9ba3d2948","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:h-lawrence-remmel-esq","object_label":"H. Lawrence Remmel, Esq.","object_source_name_forms":[],"value":"H. Lawrence Remmel, Esq.: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:h-lawrence-remmel-esq","name":"H. Lawrence Remmel, Esq."},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":true,"start_date":"2012-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2012-01-01","valid_to":null,"recorded_at":"2026-10-17T04:47:07.293807+00:00","sources":[{"id":"alpha:projection-evidence:document:06dbf8fd646217b99b9a1f4f08c0ee9f260734a5d680cc730c457a034794aa8b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ATOSSA THERAPEUTICS, INC. DEF 14A 2026-03-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000119312526131807/atos-20260330.htm","source_date":"2026-03-30","retrieved_at":"2026-04-25T00:00:04.661+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30","effective_from":"2012-01-01","effective_until":null,"observed_at":"2026-10-17T04:47:07.293807+00:00","reviewed_at":"2026-10-17T04:47:07.293807+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b045d59d-c5b2-407e-b081-16c9ba3d2948:leadership_role:6","subject_id":"alpha:company:b045d59d-c5b2-407e-b081-16c9ba3d2948","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jonathan-f-finn-c-f-a","object_label":"Jonathan F. Finn, C.F.A.","object_source_name_forms":[],"value":"Jonathan F. Finn, C.F.A.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jonathan-f-finn-c-f-a","name":"Jonathan F. Finn, C.F.A."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-17T04:47:07.293807+00:00","sources":[{"id":"alpha:projection-evidence:document:06dbf8fd646217b99b9a1f4f08c0ee9f260734a5d680cc730c457a034794aa8b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ATOSSA THERAPEUTICS, INC. DEF 14A 2026-03-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000119312526131807/atos-20260330.htm","source_date":"2026-03-30","retrieved_at":"2026-04-25T00:00:04.661+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-17T04:47:07.293807+00:00","reviewed_at":"2026-10-17T04:47:07.293807+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b045d59d-c5b2-407e-b081-16c9ba3d2948:leadership_role:7","subject_id":"alpha:company:b045d59d-c5b2-407e-b081-16c9ba3d2948","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:richard-i-steinhart","object_label":"Richard I. Steinhart","object_source_name_forms":[],"value":"Richard I. Steinhart: Director, Audit · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:richard-i-steinhart","name":"Richard I. Steinhart"},"title":"Director","role_category":"director","committee":"Audit · Chair","is_board_chair":false,"is_independent":true,"start_date":"2014-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2014-01-01","valid_to":null,"recorded_at":"2026-10-17T04:47:07.293807+00:00","sources":[{"id":"alpha:projection-evidence:document:06dbf8fd646217b99b9a1f4f08c0ee9f260734a5d680cc730c457a034794aa8b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ATOSSA THERAPEUTICS, INC. DEF 14A 2026-03-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000119312526131807/atos-20260330.htm","source_date":"2026-03-30","retrieved_at":"2026-04-25T00:00:04.661+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30","effective_from":"2014-01-01","effective_until":null,"observed_at":"2026-10-17T04:47:07.293807+00:00","reviewed_at":"2026-10-17T04:47:07.293807+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b045d59d-c5b2-407e-b081-16c9ba3d2948:leadership_role:8","subject_id":"alpha:company:b045d59d-c5b2-407e-b081-16c9ba3d2948","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:shu-chih-chen-ph-d","object_label":"Shu-Chih Chen, Ph.D.","object_source_name_forms":[],"value":"Shu-Chih Chen, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:shu-chih-chen-ph-d","name":"Shu-Chih Chen, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2009-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2009-01-01","valid_to":null,"recorded_at":"2026-10-17T04:47:07.293807+00:00","sources":[{"id":"alpha:projection-evidence:document:06dbf8fd646217b99b9a1f4f08c0ee9f260734a5d680cc730c457a034794aa8b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ATOSSA THERAPEUTICS, INC. DEF 14A 2026-03-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000119312526131807/atos-20260330.htm","source_date":"2026-03-30","retrieved_at":"2026-04-25T00:00:04.661+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30","effective_from":"2009-01-01","effective_until":null,"observed_at":"2026-10-17T04:47:07.293807+00:00","reviewed_at":"2026-10-17T04:47:07.293807+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b045d59d-c5b2-407e-b081-16c9ba3d2948:leadership_role:9","subject_id":"alpha:company:b045d59d-c5b2-407e-b081-16c9ba3d2948","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:stephen-j-galli-m-d","object_label":"Stephen J. Galli, M.D.","object_source_name_forms":[],"value":"Stephen J. Galli, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:stephen-j-galli-m-d","name":"Stephen J. Galli, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2011-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2011-01-01","valid_to":null,"recorded_at":"2026-10-17T04:47:07.293807+00:00","sources":[{"id":"alpha:projection-evidence:document:06dbf8fd646217b99b9a1f4f08c0ee9f260734a5d680cc730c457a034794aa8b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ATOSSA THERAPEUTICS, INC. DEF 14A 2026-03-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000119312526131807/atos-20260330.htm","source_date":"2026-03-30","retrieved_at":"2026-04-25T00:00:04.661+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30","effective_from":"2011-01-01","effective_until":null,"observed_at":"2026-10-17T04:47:07.293807+00:00","reviewed_at":"2026-10-17T04:47:07.293807+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b045d59d-c5b2-407e-b081-16c9ba3d2948:leadership_role:10","subject_id":"alpha:company:b045d59d-c5b2-407e-b081-16c9ba3d2948","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:steven-c-quay-m-d-ph-d","object_label":"Steven C. Quay, M.D., Ph.D.","object_source_name_forms":[],"value":"Steven C. Quay, M.D., Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:steven-c-quay-m-d-ph-d","name":"Steven C. Quay, M.D., Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2009-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2009-01-01","valid_to":null,"recorded_at":"2026-10-17T04:47:07.293807+00:00","sources":[{"id":"alpha:projection-evidence:document:06dbf8fd646217b99b9a1f4f08c0ee9f260734a5d680cc730c457a034794aa8b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ATOSSA THERAPEUTICS, INC. DEF 14A 2026-03-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000119312526131807/atos-20260330.htm","source_date":"2026-03-30","retrieved_at":"2026-04-25T00:00:04.661+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30","effective_from":"2009-01-01","effective_until":null,"observed_at":"2026-10-17T04:47:07.293807+00:00","reviewed_at":"2026-10-17T04:47:07.293807+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b045d59d-c5b2-407e-b081-16c9ba3d2948:leadership_role:11","subject_id":"alpha:company:b045d59d-c5b2-407e-b081-16c9ba3d2948","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:tessa-cigler-m-d-m-p-h","object_label":"Tessa Cigler, M.D., M.P.H.","object_source_name_forms":[],"value":"Tessa Cigler, M.D., M.P.H.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:tessa-cigler-m-d-m-p-h","name":"Tessa Cigler, M.D., M.P.H."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-17T04:47:07.293807+00:00","sources":[{"id":"alpha:projection-evidence:document:06dbf8fd646217b99b9a1f4f08c0ee9f260734a5d680cc730c457a034794aa8b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ATOSSA THERAPEUTICS, INC. DEF 14A 2026-03-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000119312526131807/atos-20260330.htm","source_date":"2026-03-30","retrieved_at":"2026-04-25T00:00:04.661+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-17T04:47:07.293807+00:00","reviewed_at":"2026-10-17T04:47:07.293807+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b045d59d-c5b2-407e-b081-16c9ba3d2948:leadership_role:12","subject_id":"alpha:company:b045d59d-c5b2-407e-b081-16c9ba3d2948","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:mark-j-daniel","object_label":"Mark J. Daniel","object_source_name_forms":[],"value":"Mark J. Daniel: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:mark-j-daniel","name":"Mark J. Daniel"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-30","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-30","valid_to":null,"recorded_at":"2026-10-17T04:47:07.293807+00:00","sources":[{"id":"alpha:projection-evidence:document:0904535d0293a2c58d7bd660355114369473a3866328d03f429b1b3d1ca99f8c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ATOS DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000119312526131807/atos-20260330.htm","source_date":"2026-03-30T00:00:00+00:00","retrieved_at":"2026-05-15T23:06:45.549278+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30T00:00:00+00:00","effective_from":"2026-03-30","effective_until":null,"observed_at":"2026-10-17T04:47:07.293807+00:00","reviewed_at":"2026-10-17T04:47:07.293807+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b045d59d-c5b2-407e-b081-16c9ba3d2948:leadership_role:13","subject_id":"alpha:company:b045d59d-c5b2-407e-b081-16c9ba3d2948","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:steven-c-quay-m-d-ph-d","object_label":"Steven C. Quay, M.D., Ph.D.","object_source_name_forms":[],"value":"Steven C. Quay, M.D., Ph.D.: Chairman of the Board, President and Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:steven-c-quay-m-d-ph-d","name":"Steven C. Quay, M.D., Ph.D."},"title":"Chairman of the Board, President and Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-30","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-30","valid_to":null,"recorded_at":"2026-10-17T04:47:07.293807+00:00","sources":[{"id":"alpha:projection-evidence:document:c3603463e57c815a7bfe458ed686f751e325d1d1f0255ef7a353f0d7db31fe39","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ATOS DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000119312526131807/atos-20260330.htm","source_date":"2026-03-30T00:00:00+00:00","retrieved_at":"2026-05-15T23:06:45.054629+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30T00:00:00+00:00","effective_from":"2026-03-30","effective_until":null,"observed_at":"2026-10-17T04:47:07.293807+00:00","reviewed_at":"2026-10-17T04:47:07.293807+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b045d59d-c5b2-407e-b081-16c9ba3d2948:committee_record:14","subject_id":"alpha:company:b045d59d-c5b2-407e-b081-16c9ba3d2948","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Richard I. Steinhart; Members Richard I. Steinhart (Chair); H. Lawrence Remmel, Esq.","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Richard I. Steinhart","members":[{"display_name":"Richard I. Steinhart","person_slug":"richard-i-steinhart","is_chair":true},{"display_name":"H. Lawrence Remmel, Esq.","person_slug":"h-lawrence-remmel-esq","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:47:07.293807+00:00","sources":[{"id":"alpha:projection-evidence:f6ec3d301d4c0f19bc71c247598f1515e024c704a82ffbc57bb048789c211f40","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1488039/000119312526131807/atos-20260330.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:47:07.293807+00:00","reviewed_at":"2026-10-17T04:47:07.293807+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:06dbf8fd646217b99b9a1f4f08c0ee9f260734a5d680cc730c457a034794aa8b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ATOSSA THERAPEUTICS, INC. DEF 14A 2026-03-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000119312526131807/atos-20260330.htm","source_date":"2026-03-30","retrieved_at":"2026-04-25T00:00:04.661+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:0904535d0293a2c58d7bd660355114369473a3866328d03f429b1b3d1ca99f8c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ATOS DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000119312526131807/atos-20260330.htm","source_date":"2026-03-30T00:00:00+00:00","retrieved_at":"2026-05-15T23:06:45.549278+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:c3603463e57c815a7bfe458ed686f751e325d1d1f0255ef7a353f0d7db31fe39","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ATOS DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000119312526131807/atos-20260330.htm","source_date":"2026-03-30T00:00:00+00:00","retrieved_at":"2026-05-15T23:06:45.054629+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:f6ec3d301d4c0f19bc71c247598f1515e024c704a82ffbc57bb048789c211f40","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1488039/000119312526131807/atos-20260330.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.842,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.838,"cross_source_agreement":0.75,"temporal_completeness":0.818},"diagnostics":{"published_claims":16,"factual_claims":16,"claims_with_linked_evidence":16,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":11,"temporal_claims_with_valid_from":9,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:47:07.293807+00:00","observed_at":"2026-10-17T04:47:07.293807+00:00","reviewed_at":"2026-10-17T04:47:07.293807+00:00","verified_at":"2026-10-17T04:47:07.293807+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":16,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/atossa-therapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/atossa-therapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}